Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23122534 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study of Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Adult Patients With Allergic Grass Pollen Rhinoconjunctivitis
Condition: Grass Pollen-related Allergic Rhinoconjunctivitis
Interventions: Biological: Grass pollen allergen extract;   Drug: Placebo tablet

Indicates status has not been verified in more than two years